ArticlePreventive medicine2025
A content analysis of cannabis edible product characteristics, packaging features, and online promotions.
Article in Preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- "Cannabis Green Wave" versus "Nicotine Freeze": the regulatory paradox of cannabis liberalization and nicotine prohibition.Harm reduction journal · 2026Article
- An update on cannabis products, cannabinoid content, plant type, and prices five years after legalization in Ontario, Canada.Journal of cannabis research · 2026Article
- Standardizing Recreational Cannabis Excise Tax Rates in the United States: New Retail Price-Based Measurements by Product Category.International journal of environmental research and public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectiveAs legal cannabis markets expand in the United States, edibles have become increasingly popular, particularly among youth. This study aimed to assess cannabis edible product characteristics, packaging features, and online promotions that may be appealing or misleading to consumers.
methodsDuring November 2023 and August 2024, we identified active online cannabis dispensaries in the United States from the National Cannabis Industry Association's member directory and conducted a content analysis of 2282 cannabis edible products to assess front-of-package information on product characteristics, child-oriented features, health and non-health claims, warnings, as well as online promotional strategies.
resultsOver half of the products were gummies, and more than 80 % contained at least 100 mg of total tetrahydrocannabinol (THC). Few packages included individual packaging or serving size information. Child-appealing elements were prevalent: over 20 % of products displayed animated or human-like characters, nearly all products were flavored with fruit flavor being the most common, and more than half featured packaging with four or more colors. Non-health claims appeared on 27.7 % of products, cannabis-infused labels on 48.1 %, and underage use warnings on 16.4 %. Product-specific promotions were present for 77.0 % of products, and nearly all had storewide promotions.
conclusionsCannabis companies frequently utilized marketing strategies that may make edibles appealing or misleading to consumers, particularly youth. Further research understanding how these marketing strategies influence consumer perceptions and appeal is needed to inform regulations on cannabis packaging and promotion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.